1.
Pharmacokinetic Behavior of PEG-IFNα2b in SD Rats
聚乙二醇干扰素α2b在SD大鼠体内的药代动力学特征
2.
Treatment of Peginterferon alfa-2a on Patients with Chronic Hepatitis B
聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎
3.
The Relationship between Efficacy of PEG-interferon and HLA-DRB1 Alleles in the Patients with Chronic Hepatitis B;
慢性乙型肝炎聚乙二醇干扰素疗效与HLA-DRB1等位基因的相关性研究
4.
Clinlical Effect and Safety of Pegylated Interferonɑ-2a in the Treatment of Chronic Hepatitis B;
聚乙二醇化干扰素ɑ-2a治疗慢性乙型肝炎的疗效与安全性
5.
Efficacy of Peginterferon α-2a in HBeAg Positive Chronic Hepatitis B:Meta-analysis Study
聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎的Meta分析
6.
Studies on related molecules to virological response to polyethylene glycol-interferon-alpha-2a therapy in patients with chronic hepatitis B
聚乙二醇干扰素α2a治疗慢性乙型肝炎病毒学应答的相关分子研究
7.
Clinical study of peg-interferon-alpha 2a antiviral therapy in patients with chronic hepatitis B
聚乙二醇干扰素α-2a治疗慢性乙型肝炎临床分析
8.
Study on Characterization of Polyethylene Glycolylated Recombinant Human Interferon α_(2b) and Preparation of Protective Additive in Freeze-drying Formulation;
聚乙二醇化重组人干扰素α_（2b）性质及冻干保护剂的研究
9.
Study on the Anti-hepatitis B Virus with Peg-IFNα-2a and IFNα-2a in Vitro and in Vivo;
聚乙二醇化干扰素α-2a与干扰素α-2a在体内和体外的抗乙型肝炎病毒活性研究
10.
Study on Pharmacokinetics of Recombinant Human IFN-ω Modified with PEG;
聚乙二醇修饰重组人干扰素ω的药代动力学研究
11.
Clinical Studies on the Combination of PEG-IFN α-2a with RBV to Treat Chronic Hepatitis C;
聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎的临床研究
12.
Different Methods to Determine the Purity of PEGylated Recombinant Human Interferon α-2b Injection
不同方法测定聚乙二醇化重组人干扰素α-2b注射液的纯度
13.
Treatment on Patients with Chronic Hepatitis C by Peginterferon with Ribavirin
聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎临床观察
14.
Study on Characterization of PEGylated and Native Consensus Interferon α
重组复合α干扰素及其聚乙二醇化修饰产物理化性质研究
15.
Case analysis of antigenic diversion of HBsAg in the patients treated with pegylated interferon α-2a
聚乙二醇干扰素α-2a治疗慢性乙型病毒性肝炎HBsAg转阴影响因素分析
16.
Factors that predict response of pegylated interferon α-2a on antigenic deversion of HBsAg among chronic hepatitis B patients
聚乙二醇化干扰素α-2a治疗慢性乙型肝炎发生HBsAg转阴的相关因素探讨
17.
The Analysis of Early Virological Response and Sustained Virological Response on Chronic Hepatitis B Patients with PEG Interferon α-2a Treatment;
聚乙二醇干扰素α-2a治疗慢性乙肝患者的早期应答与持久应答关系分析
18.
A Cost-effectiveness Analysis of Peginterferon and Nucleoside Analogues for HBeAg-Positive Chronic Hepatits B
聚乙二醇干扰素和核苷类似物治疗e抗原阳性慢性乙型肝炎成本效果分析